High-dose Methylprednisolone and Rituximab in High Risk B-CLL

Clinical trial NCT00558181 · COMPLETED

Trial details

NCT number: NCT00558181
Sponsor: Vilnius University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic B-Lymphocytic Leukemia

Start date: 2007-09-01
Primary completion: 2009-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.